Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis and herpesvirus interaction.
Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Detection of reduced interhemispheric cortical communication during task execution in multiple sclerosis patients using functional near-infrared spectroscopy.
Diverse functional roles of lipocalin-2 in the central nervous system.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
Glia in mammalian development and disease.
Natalizumab-induced hepatic injury: A case report and review of literature.
Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
Cervical dysplasia associated with the use of natalizumab.
Treatment of primary progressive multiple sclerosis.
Therapeutic decision making in a new drug era in multiple sclerosis.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
A Surprisingly Low Prevalence of Demonstrable Stress Urinary Incontinence and Pelvic Organ Prolapse in Women with Multiple Sclerosis Followed at a Tertiary Neurogenic Bladder Clinic.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Distinguishing Susac's syndrome from multiple sclerosis.
[Special cases of multiple sclerosis].
Pages
« first
‹ previous
…
264
265
266
267
268
269
270
271
272
…
next ›
last »